|
Back
to Product News Main Page
A New "Eye" of Visualization
FemSuite LLC recently unveiled a new portable, intravaginal scope
(FemEye One) intended for video documentation, visualization, and
patient education. Producing digital videos and photos via a USB
port connected to a handheld monitor that is also PC compatible,
the intravaginal scope provides physicians with sufficient, comprehensive
images to make in-office diagnoses. The scope’s disposable
protective sheaths eliminate the costly and time-
consuming sterilization process.
back to top
New Indication for
Oral Contraceptive
The US Food and Drug Administration (FDA) recently approved Berlex,
Inc's application for the expanded use of their oral contraceptive
(OC), 3 mg drospirenone/20 mcg ethinyl estradiol (Yaz), for the
treatment of moderate acne vulgaris in women also desiring contraception.
Already approved for the treatment of the physical and emotional
symptoms related to premenstrual dysphoric disorder, Berlex's
product is the first FDA-approved OC for three distinct indications.
back to top
Simplifying Treatment
Shire PLC recently received FDA approval for their oral mesalamine
tablets (Lialda) indicated for inducing remission in patients with
active, mild-to-moderate ulcerative colitis. Available in two dosages,
mesalamine 2.4 g/d and 4.8 g/d are
the first FDA-approved once-daily oral medications of mesalamine.
The high mesalamine content per dose significantly reduces the number
of daily
tablets previously required for patient treatment.
back to top
Improving Prenatal Care
Everett Laboratories, Inc, recently announced the introduction of
a new combination vitamin and mineral supplement, plus docahexaenoic
acid (DHA), daily-dose caplet system (Vitafol-OB+DHA) for prenatal
care. Consisting
of 15 essential minerals, the new prenatal supplement contains
1 mg of folic acid and 65 mg of elemental iron. The separate DHA
capsule is intended to
improve infant visual and nervous system development, and foster
maternal heart health and well being.
back to top
|
